SCHEMBL24729192

SCHEMBL24729192

O=C(OCc1ccccc1)c1ccccc1N(C(=O)OCc1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.56
TDP1 Q9NUW8 3/20 0.55
L3MBTL1 Q9Y468 5/20 0.49
TSHR P16473 3/20 0.49
CYP3A4 P08684 2/20 0.49
MAPK1 P28482 2/20 0.49
SLC6A2 P23975 1/20 0.49
SLC6A3 Q01959 1/20 0.49
KMT2A Q03164 1/20 0.49
CASP3 P42574 1/20 0.48
RAB9A P51151 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9680281 0.83 ALDH1A1 (0.55) ALDH1A1TDP1L3MBTL1MAPK1SLC6A2
SCHEMBL24729148 0.81 ALDH1A1 (0.44) ALDH1A1TDP1L3MBTL1MAPK1SLC6A2
SCHEMBL24729191 0.81 ALDH1A1 (0.58) ALDH1A1TDP1L3MBTL1TSHRCYP3A4
SCHEMBL12869898 0.79 ALDH1A1 (0.63) ALDH1A1TDP1L3MBTL1TSHRCYP3A4
SCHEMBL29388715 0.78 ALDH1A1 (0.89) ALDH1A1TDP1L3MBTL1TSHRCYP3A4
SCHEMBL50441 0.78 ALDH1A1 (0.89) ALDH1A1TDP1L3MBTL1TSHRCYP3A4
SCHEMBL7183167 0.74 TSHR (0.46) ALDH1A1L3MBTL1TSHRKMT2ARAB9A
SCHEMBL9135166 0.73 ALDH1A1 (0.52) ALDH1A1TDP1L3MBTL1MAPK1SLC6A2
SCHEMBL28114187 0.73 ALDH1A1 (0.55) ALDH1A1TDP1L3MBTL1TSHRCYP3A4
SCHEMBL29837154 0.73 ALDH1A1 (0.43) ALDH1A1TDP1L3MBTL1MAPK1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11437591-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11437591-B2 Organic electroluminescent materials and devices OCIAD2, EML4, KCNJ2 ALDH1A1 534/4885TDP1 2070/4885L3MBTL1 1544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.